IBX 17.7% 4.0¢ imagion biosystems limited

Human Trial, page-41

  1. 784 Posts.
    lightbulb Created with Sketch. 370
    It is a MagSense Trial.

    "MagSense™ HER2 Phase I study for metastatic breast cancer" is the name given to the study in the HREC approval announcement.
 
watchlist Created with Sketch. Add IBX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.006(17.7%)
Mkt cap ! $1.399M
Open High Low Value Volume
3.4¢ 4.0¢ 3.4¢ $1.437K 39.38K

Buyers (Bids)

No. Vol. Price($)
1 1942 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 25112 3
View Market Depth
Last trade - 16.10pm 15/08/2024 (20 minute delay) ?
IBX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.